MCID: MYL003
MIFTS: 48

Myeloid Sarcoma malady

Categories: Rare diseases, Cancer diseases, Blood diseases, Immune diseases

Aliases & Classifications for Myeloid Sarcoma

Aliases & Descriptions for Myeloid Sarcoma:

Name: Myeloid Sarcoma 12 50 56 14
Granulocytic Sarcoma 12 50 56 69
Extramedullary Myeloid Tumor 12 50 56
Chloroma 12 50 56
Sarcoma Granulocytic 52
Sarcoma, Myeloid 42

Characteristics:

Orphanet epidemiological data:

56
myeloid sarcoma
Inheritance: Not applicable; Age of onset: All ages;

Classifications:



External Ids:

Disease Ontology 12 DOID:8683
ICD10 33 C92.3 C92.30
ICD9CM 35 205.3
MeSH 42 D023981
NCIt 47 C3520 C35815
Orphanet 56 ORPHA86850
MESH via Orphanet 43 D023981
ICD10 via Orphanet 34 C92.3
UMLS 69 C0152276

Summaries for Myeloid Sarcoma

MalaCards based summary : Myeloid Sarcoma, also known as granulocytic sarcoma, is related to acute leukemia and sarcoma. An important gene associated with Myeloid Sarcoma is MPO (Myeloperoxidase), and among its related pathways/superpathways are NF-kappaB Signaling and Transcriptional misregulation in cancer. The drugs Cyclophosphamide and Fludarabine have been mentioned in the context of this disorder. Affiliated tissues include myeloid, bone and bone marrow, and related phenotypes are Increased shRNA abundance (Z-score > 2) and cellular

Wikipedia : 71 A myeloid sarcoma (chloroma, granulocytic sarcoma,extramedullary myeloid tumor), is a solid tumor... more...

Related Diseases for Myeloid Sarcoma

Diseases related to Myeloid Sarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 118)
id Related Disease Score Top Affiliating Genes
1 acute leukemia 29.3 DNTT FLT3 KMT2A MPO
2 sarcoma 10.8
3 leukemia 10.4
4 myeloid leukemia 10.3
5 acute motor-sensory axonal neuropathy 10.3 FLT3 MPO
6 acute zonal occult outer retinopathy 10.2 FLT3 NPM1
7 hodgkin's lymphoma, lymphocytic depletion 10.2 MPO PTPRC
8 congenital sucrase-isomaltase deficiency with starch and lactose intolerance 10.2 NPM1 PTPRC
9 intracranial sinus thrombosis 10.2 KIT MPO
10 hinman syndrome 10.1 PAX5 PTPRC
11 spinal cord intramedullary teratoma 10.1 DNTT PTPRC
12 subacute delirium 10.1 PAX5 PTPRC
13 unilateral hemispheric polymicrogyria 10.1 FLT3 KIT
14 bork stender schmidt syndrome 10.1 NCAM1 NPM1
15 paranasal sinus cancer 10.1 KIT PAX5
16 congenital disorder of glycosylation, type iq 10.1 KIT MPO
17 desmoid tumor 10.1 DNTT MPO PTPRC
18 acute necrotizing encephalopathy 10.1 KMT2A MPO
19 hyperandrogenism due to cortisone reductase deficiency 10.1 FLT3 KIT
20 uterine corpus myxoid leiomyosarcoma 10.1 NCAM1 PTPRC
21 freemartinism 10.1 KIT PTPRC
22 estrogen-receptor negative breast cancer 10.1 NPM1 PTPRC
23 glomus tumor 10.1 KIT NCAM1
24 rhabdoid cancer 10.1 KIT PTPRC
25 choriocarcinoma of ovary 10.1 KIT PTPRC
26 ovarian germ cell teratoma 10.1 KIT NCAM1
27 cerebral arterial disease 10.0 KIT PTPRC
28 fallopian tube leiomyoma 10.0 KIT PTPRC
29 fragile x-associated tremor/ataxia syndrome 10.0 KIT NCAM1
30 lip cancer 10.0 NPM1 PAX5 PTPRC
31 endodermal sinus tumor 10.0 KIT PTPRC
32 aortic arch interruption 10.0 NPM1 PAX5 PTPRC
33 microsporidiosis 10.0 KIT NCAM1
34 actinobacillosis 10.0 FLT3 KIT MPO
35 acute respiratory distress syndrome 10.0 FLT3 KIT NPM1
36 carnitine-acylcarnitine translocase deficiency 10.0 NPM1 PAX5 PTPRC
37 agammaglobulinemia 8, autosomal dominant 10.0 FLT3 KIT NPM1
38 acute perichondritis of pinna 10.0 KIT MPO
39 peroxisome biogenesis disorder 7a 10.0 DNTT FLT3 KIT
40 mental retardation, autosomal dominant 26 10.0 KMT2A NPM1
41 cranial nerve disease 10.0 KIT NCAM1
42 ethmoid sinus schneiderian papilloma 10.0 NCAM1 PTPRC
43 dupuytren contracture 10.0 FLT3 KIT
44 pancreatic agenesis 10.0 KIT NCAM1
45 basal ganglia disease 10.0 NCAM1 PAX5
46 adult respiratory distress syndrome 9.9 FLT3 KMT2A MPO
47 glycogen storage disease type 0 9.9 FLT3 KMT2A NPM1
48 myelodysplastic syndrome 9.9
49 meige syndrome 9.9 KIT NCAM1 PAX5
50 pulmonary fibrosis, idiopathic 9.9 DNTT NPM1 PAX5 PTPRC

Graphical network of the top 20 diseases related to Myeloid Sarcoma:



Diseases related to Myeloid Sarcoma

Symptoms & Phenotypes for Myeloid Sarcoma

GenomeRNAi Phenotypes related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-100 10.06 MPO
2 Increased shRNA abundance (Z-score > 2) GR00366-A-102 10.06 KIT FLT3 DNTT
3 Increased shRNA abundance (Z-score > 2) GR00366-A-115 10.06 FLT3
4 Increased shRNA abundance (Z-score > 2) GR00366-A-120 10.06 FLT3
5 Increased shRNA abundance (Z-score > 2) GR00366-A-121 10.06 FLT3
6 Increased shRNA abundance (Z-score > 2) GR00366-A-122 10.06 FLT3
7 Increased shRNA abundance (Z-score > 2) GR00366-A-123 10.06 FLT3 DNTT
8 Increased shRNA abundance (Z-score > 2) GR00366-A-126 10.06 MPO
9 Increased shRNA abundance (Z-score > 2) GR00366-A-138 10.06 DNTT
10 Increased shRNA abundance (Z-score > 2) GR00366-A-151 10.06 DNTT
11 Increased shRNA abundance (Z-score > 2) GR00366-A-152 10.06 KIT
12 Increased shRNA abundance (Z-score > 2) GR00366-A-157 10.06 KIT MPO DNTT
13 Increased shRNA abundance (Z-score > 2) GR00366-A-16 10.06 DNTT
14 Increased shRNA abundance (Z-score > 2) GR00366-A-163 10.06 FLT3
15 Increased shRNA abundance (Z-score > 2) GR00366-A-170 10.06 KIT
16 Increased shRNA abundance (Z-score > 2) GR00366-A-176 10.06 MPO
17 Increased shRNA abundance (Z-score > 2) GR00366-A-182 10.06 DNTT
18 Increased shRNA abundance (Z-score > 2) GR00366-A-186 10.06 MPO
19 Increased shRNA abundance (Z-score > 2) GR00366-A-197 10.06 DNTT
20 Increased shRNA abundance (Z-score > 2) GR00366-A-25 10.06 FLT3
21 Increased shRNA abundance (Z-score > 2) GR00366-A-29 10.06 MPO
22 Increased shRNA abundance (Z-score > 2) GR00366-A-30 10.06 KIT
23 Increased shRNA abundance (Z-score > 2) GR00366-A-36 10.06 MPO
24 Increased shRNA abundance (Z-score > 2) GR00366-A-42 10.06 KIT
25 Increased shRNA abundance (Z-score > 2) GR00366-A-57 10.06 MPO
26 Increased shRNA abundance (Z-score > 2) GR00366-A-7 10.06 MPO
27 Increased shRNA abundance (Z-score > 2) GR00366-A-70 10.06 FLT3 MPO
28 Increased shRNA abundance (Z-score > 2) GR00366-A-73 10.06 DNTT
29 Increased shRNA abundance (Z-score > 2) GR00366-A-85 10.06 KIT
30 Increased shRNA abundance (Z-score > 2) GR00366-A-9 10.06 KIT
31 Increased shRNA abundance (Z-score > 2) GR00366-A-99 10.06 KIT

MGI Mouse Phenotypes related to Myeloid Sarcoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.87 FLT3 KIT KMT2A NCAM1 NPM1 PAX5
2 hematopoietic system MP:0005397 9.86 DNTT FLT3 KIT KMT2A MPO NPM1
3 immune system MP:0005387 9.76 KMT2A MPO NPM1 PAX5 PTPRC DNTT
4 mortality/aging MP:0010768 9.56 FLT3 KIT KMT2A MPO NCAM1 NPM1
5 neoplasm MP:0002006 9.1 FLT3 KIT KMT2A NPM1 PAX5 PTPRC

Drugs & Therapeutics for Myeloid Sarcoma

Drugs for Myeloid Sarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 199)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
2
Fludarabine Approved Phase 3,Phase 2,Phase 1 21679-14-1, 75607-67-9 30751
3
Busulfan Approved, Investigational Phase 3,Phase 2,Phase 1 55-98-1 2478
4
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
5
Daunorubicin Approved Phase 3 20830-81-3 30323
6
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
7
Idarubicin Approved Phase 3 58957-92-9 42890
8
Cytarabine Approved, Investigational Phase 3,Phase 2 147-94-4 6253
9
Methotrexate Approved Phase 3 1959-05-2, 59-05-2 126941
10
Hydrocortisone Approved, Vet_approved Phase 3 50-23-7 5754 657311
11
Lenograstim Approved Phase 3,Phase 2,Phase 1 135968-09-1
12
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
13
Thioguanine Approved Phase 3 154-42-7 2723601
14
Aldesleukin Approved Phase 3,Phase 2,Phase 1 85898-30-2, 110942-02-4
15
Asparaginase Approved Phase 3 9015-68-3
16
Mitoxantrone Approved, Investigational Phase 3,Phase 2 65271-80-9 4212
17
Sorafenib Approved, Investigational Phase 3,Phase 2 284461-73-0 216239 406563
18
Bortezomib Approved, Investigational Phase 3 179324-69-7 387447 93860
19
Histamine Approved, Investigational Phase 3 75614-87-8, 51-45-6 774
20
Cyproheptadine Approved Phase 3 129-03-3 2913
21
leucovorin Approved, Nutraceutical Phase 3 58-05-9 54575, 6560146 143
22
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
23
Niacin Approved, Investigational, Nutraceutical Phase 3 59-67-6 938
24
Nicotinamide Approved, Nutraceutical Phase 3 98-92-0 936
25
Butyric Acid Experimental Phase 3 107-92-6 264
26 Alkylating Agents Phase 3,Phase 2,Phase 1
27 glucocorticoids Phase 3,Phase 2
28 Gastrointestinal Agents Phase 3,Phase 2
29 Hormone Antagonists Phase 3,Phase 2
30 Hormones Phase 3,Phase 2
31 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1
32 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2
33 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
34 Antiemetics Phase 3,Phase 2
35 Anti-Inflammatory Agents Phase 3,Phase 2
36 Antimetabolites Phase 3,Phase 2,Phase 1
37 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1
38 Antirheumatic Agents Phase 3,Phase 2,Phase 1
39 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
40 Autonomic Agents Phase 3,Phase 2
41 Antineoplastic Agents, Hormonal Phase 3,Phase 2,Phase 1
42 pancreatic polypeptide Phase 3
43 Dexamethasone acetate Phase 3 1177-87-3
44 Interleukin-2 Phase 3,Phase 2,Phase 1
45 Analgesics Phase 3,Phase 2,Phase 1
46 Adjuvants, Anesthesia Phase 3
47 Folic Acid Antagonists Phase 3
48 Narcotics Phase 3
49 Cortisol succinate Phase 3
50 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 66)
id Name Status NCT ID Phase
1 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome Completed NCT00002798 Phase 3
2 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
3 A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families Completed NCT00782145 Phase 3
4 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
5 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Completed NCT01305200 Phase 3
6 Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Recruiting NCT01371981 Phase 3
7 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3
8 Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Unknown status NCT00675870 Phase 2
9 Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases Unknown status NCT00084695 Phase 2
10 Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation Unknown status NCT00036712 Phase 2
11 Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma Completed NCT00189137 Phase 2
12 Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect Completed NCT00003425 Phase 1, Phase 2
13 Combination Chemotherapy in Treating Patients With Advanced Cancer Completed NCT00004105 Phase 1, Phase 2
14 Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease Completed NCT00118326 Phase 1, Phase 2
15 Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy Completed NCT00066599 Phase 2
16 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
17 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
18 Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant Completed NCT00309907 Phase 2
19 NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) Completed NCT01386619 Phase 1, Phase 2
20 Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes Completed NCT00171912 Phase 2
21 Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib Completed NCT01831726 Phase 2
22 BKM120 for Patients With PI3K-activated Tumors Completed NCT01833169 Phase 2
23 CIP-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma Recruiting NCT02484391 Phase 2
24 Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia Recruiting NCT02658487 Phase 2
25 Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation Recruiting NCT02790515 Phase 2
26 PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Recruiting NCT02390752 Phase 1, Phase 2
27 Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy Recruiting NCT01871766 Phase 2
28 A Pilot RCT of the PRISM Intervention for AYAs With Cancer Recruiting NCT02340884 Phase 2
29 Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Active, not recruiting NCT01154816 Phase 2
30 Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation Terminated NCT02259348 Phase 2
31 T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant Terminated NCT01621477 Phase 2
32 Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant Withdrawn NCT00728585 Phase 2
33 Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors Completed NCT00640796 Phase 1
34 Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors Completed NCT00093821 Phase 1
35 Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy Completed NCT00030108 Phase 1
36 Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor Completed NCT00161187 Phase 1
37 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer Completed NCT00045006 Phase 1
38 Busulfan in Treating Children and Adolescents With Refractory CNS Cancer Completed NCT00006246 Phase 1
39 Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer Completed NCT00004065 Phase 1
40 Dendritic Cell Vaccine With or Without Gemcitabine Pre-Treatment for Adults and Children With Sarcoma Recruiting NCT01803152 Phase 1
41 Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors Recruiting NCT02390843 Phase 1
42 Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies Recruiting NCT02561988 Phase 1
43 A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies Recruiting NCT02498665 Phase 1
44 Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies Recruiting NCT02223052 Phase 1
45 TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate Recruiting NCT02508038 Phase 1
46 Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 Not yet recruiting NCT02890758 Phase 1
47 Nonmyeloablative Allogeneic Transplant Unknown status NCT01272817
48 Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer Unknown status NCT00349024
49 Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer Unknown status NCT01295463
50 PET-CT in AML for Detection of Extramedullary AML Manifestations Completed NCT01278069

Search NIH Clinical Center for Myeloid Sarcoma

Cochrane evidence based reviews: sarcoma, myeloid

Genetic Tests for Myeloid Sarcoma

Anatomical Context for Myeloid Sarcoma

MalaCards organs/tissues related to Myeloid Sarcoma:

39
Myeloid, Bone, Bone Marrow, Breast, Skin, Liver, Prostate

Publications for Myeloid Sarcoma

Articles related to Myeloid Sarcoma:

(show top 50) (show all 305)
id Title Authors Year
1
Encapsulated relapsed flt3+AML (myeloid sarcoma) and hurthle cell adenoma presenting in composite: unlikely partners. ( 27643393 )
2016
2
Myeloid Sarcoma of the Hepatobiliary System: A Case Series and Review of the Literature. ( 27007946 )
2016
3
Cytokeratin-type intermediate filaments in a gastric myeloid sarcoma: a diagnostic pitfall. ( 28092890 )
2016
4
The progression of CD56(+) myeloid sarcoma: A case report and literature review. ( 27123069 )
2016
5
Clinicopathological features of myeloid sarcoma: Report of 39 cases and literature review. ( 27515547 )
2016
6
Sacral Spine Myeloid Sarcoma. ( 27053987 )
2016
7
Bilateral orbital myeloid sarcoma preceding acute myeloid leukemia in an adult: a case report and review of the literature. ( 26846095 )
2016
8
Myeloid sarcoma of the periprostatic tissue and prostate: Case report and review of literature. ( 27453659 )
2016
9
Isolated myeloid sarcoma. ( 27560717 )
2016
10
Myeloid Sarcoma in an Eyelid That Developed during Chemotherapy for Acute Myeloid Leukemia. ( 26889156 )
2016
11
Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. ( 27152845 )
2016
12
Orbital myeloid sarcoma: Rare presentation of AML. ( 27074545 )
2016
13
Do Not Forget the Glycophorin A: An Unusual Case of Myeloid Sarcoma. ( 26907661 )
2016
14
A rare case of dorsal-cervical spine myeloid sarcoma detected on (18)F-FDG PET/CT scan. ( 27498227 )
2016
15
De novo myeloid sarcoma involving mandible in a child: Report of a rare occurrence. ( 27601827 )
2016
16
Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing. ( 27659839 )
2016
17
Low back pain and femoral neuralgia revealing myeloid sarcoma with megakaryocytic differentiation. ( 26992956 )
2016
18
Myeloid sarcomas of the head and neck in pediatric patients with myeloid leukemia. ( 27657319 )
2016
19
Myeloid sarcoma of the Gingiva with myelodysplastic syndrome: A Case Report. ( 27310987 )
2016
20
Evidence for a role of decitabine in the treatment of myeloid sarcoma. ( 27817041 )
2016
21
Cardiac Myeloid Sarcoma - Multimodality Radiologic Imaging Features and Pathologic Correlation. ( 27103046 )
2016
22
Isochromosome 17q; A Novel Finding in Myeloid Sarcoma. ( 27980303 )
2016
23
Bilateral Myeloid Sarcoma of Breast in a Young Male Occurring after 11 Years of Chronic Myeloid Leukemia Diagnosis: A Unique Pattern of Relapse. ( 27488267 )
2016
24
Myeloid Sarcoma Presenting as Low Back Pain in the Pediatric Emergency Department. ( 27395325 )
2016
25
Hypercalcemia and diffuse osteolytic lesions in a 45-year-old patient with myeloid sarcoma with megakaryocytic differentiation. ( 27124159 )
2016
26
Myeloid sarcoma of the orbit without systemic recurrence of disease in an adult: A clinicopathological case report. ( 26905183 )
2016
27
Primary Myeloid Sarcoma of the Small Intestine: Case Report and Literature Review. ( 27509642 )
2016
28
Isolated Uterine Myeloid Sarcoma Preceding the Diagnosis of Acute Myeloid Leukemia. ( 27376223 )
2016
29
Myeloid Sarcoma in the Orbit. ( 27977030 )
2016
30
Shoulder Myeloid Sarcoma: An Initial Presentation of CML Blast Crisis. ( 27408438 )
2016
31
Multimodality imaging and histopathology of cardiac myeloid sarcoma. ( 27458183 )
2016
32
A Case of Myeloid Sarcoma of Intestine. ( 27646584 )
2016
33
Case Report: Myelodysplastic syndrome- associated myeloid sarcoma: an unusual clinical presentation of a rare disease. ( 27019694 )
2016
34
Re: FDG PET/CT Findings of Intracardiac Myeloid Sarcoma. ( 27819854 )
2016
35
Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients. ( 27631510 )
2016
36
Spontaneous remission of aleukemic cutaneous myeloid sarcoma followed by crisis of acute monoblastic leukemia. ( 26661142 )
2016
37
Myeloid Sarcoma: Presenting with Massive Cervical and Inguinal Lymphadenopathy. ( 27395055 )
2016
38
Myeloid sarcoma derived from the gastrointestinal tract: A case report and review of the literature. ( 27313759 )
2016
39
Leukaemic blast cannibalism in acute megakaryoblastic leukaemia with myeloid sarcoma. ( 27030205 )
2016
40
Hepatic myeloid sarcoma diagnosed at autopsy: A case report. ( 27773146 )
2016
41
Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey. ( 28056398 )
2016
42
Isolated spinal myeloid sarcoma with rapid progression. ( 26828010 )
2016
43
Myeloid Sarcoma Of Vulva: A Short Update. ( 27408359 )
2016
44
Myeloid sarcoma presenting as a colon polyp and harbinger of chronic myelogenous leukemia. ( 26989468 )
2016
45
Central nervous system involvement by myeloid sarcoma: a report of 12 cases and review of the literature. ( 27125868 )
2016
46
Myeloid sarcoma of submandibular salivary gland. ( 27489709 )
2016
47
Myeloid sarcoma: An unusual and rare laryngeal presentation. ( 26957189 )
2016
48
A t(8;9)(p22;p24)/PCM1-JAK2 Translocation in a Patient With Myeloproliferative Neoplasm and Myeloid Sarcoma: First Report in Korea. ( 26522767 )
2016
49
Bilateral Aleukemic Myeloid Sarcoma of the Eyelids With Indolent Course. ( 26863061 )
2016
50
Extramedullary Myeloid Sarcoma of Bilateral Breast as First Manifestation of Acute Myeloid Leukemia-A Diagnostic Challenge. ( 26391427 )
2015

Variations for Myeloid Sarcoma

Expression for Myeloid Sarcoma

Search GEO for disease gene expression data for Myeloid Sarcoma.

Pathways for Myeloid Sarcoma

GO Terms for Myeloid Sarcoma

Cellular components related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.8 KIT NCAM1 PTPRC

Biological processes related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.37 FLT3 KIT
2 visual learning GO:0008542 9.32 KIT KMT2A
3 T cell differentiation GO:0030217 9.26 KIT PTPRC
4 positive regulation of phosphatidylinositol 3-kinase activity GO:0043552 9.16 FLT3 KIT
5 embryonic hemopoiesis GO:0035162 8.96 KIT KMT2A
6 myeloid progenitor cell differentiation GO:0002318 8.62 FLT3 KIT

Molecular functions related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protein homodimerization activity GO:0042803 8.92 FLT3 KIT KMT2A NPM1

Sources for Myeloid Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....